Parents
Sign in to add mentor| Raymond Pierce | grad student | 2004 | Lille 2 | |
| (Caractérisation fonctionnelle d'un récepteur nucléaire de la famille FTZ-F1 (Fushi Tarazu-Factor 1) chez le parasite trématode schistosoma mansoni) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Fumery M, Speca S, Langlois A, et al. (2017) Peroxisome proliferator-activated receptor gamma (PPARγ) regulates lactase expression and activity in the gut. Embo Molecular Medicine |
| Martin Mena A, Langlois A, Speca S, et al. (2017) The Expression of the Short Isoform of Thymic Stromal Lymphopoietin in the Colon Is Regulated by the Nuclear Receptor Peroxisome Proliferator Activated Receptor-Gamma and Is Impaired during Ulcerative Colitis. Frontiers in Immunology. 8: 1052 |
| Speca S, Rousseaux C, Dubuquoy C, et al. (2016) Novel PPARγ Modulator GED-0507-34 Levo Ameliorates Inflammation-driven Intestinal Fibrosis. Inflammatory Bowel Diseases. 22: 279-92 |
| Mena AM, Langlois A, Desreumaux P, et al. (2016) Sa1846 The Expression of the Short Isoform of TSLP in the Colon Is Regulated by the Nuclear Receptor PPARγ and Is Impaired During Ulcerative Colitis Gastroenterology. 150 |
| Speca S, Fumery M, Langlois A, et al. (2016) 979 Modulating Peroxisome Proliferator-Activated Receptor Gamma (PPARγ): A Potential New Therapeutic Strategy for Lactose Intolerance Gastroenterology. 150 |
| Bouguen G, Langlois A, Djouina M, et al. (2015) Intestinal steroidogenesis controls PPARγ expression in the colon and is impaired during ulcerative colitis. Gut. 64: 901-10 |
| Gensollen T, Bourges C, Rihet P, et al. (2013) Functional polymorphisms in the regulatory regions of the VNN1 gene are associated with susceptibility to inflammatory bowel diseases. Inflammatory Bowel Diseases. 19: 2315-25 |
| Bertin B, Dubuquoy L, Colombel JF, et al. (2013) PPAR-gamma in ulcerative colitis: a novel target for intervention. Current Drug Targets. 14: 1501-7 |
| El-Jamal N, Dubuquoy L, Auwerx J, et al. (2013) In vivo imaging reveals selective PPAR activity in the skin of peroxisome proliferator-activated receptor responsive element-luciferase reporter mice. Experimental Dermatology. 22: 137-40 |
| Fréville A, Landrieu I, García-Gimeno MA, et al. (2012) Plasmodium falciparum inhibitor-3 homolog increases protein phosphatase type 1 activity and is essential for parasitic survival. The Journal of Biological Chemistry. 287: 1306-21 |